bioRxivCancer BiologyPreprint
Unraveling the Connections between Calreticulin and Myeloproliferative Neoplasms via Calcium Signalling
Abstract
Mutations in the form of insertions and deletions (INDEL) in the calreticulin gene lead to essential thrombocythemia which is characterized by the formation of thrombosis. However, the connection between calreticulin INDEL and essential thrombocythemia remains largely elusive. Through combined molecular dynamics simulation and in-vitro studies on the wild type and mutated isoforms of calreticulin, the mechanism underlying the calreticulin INDEL induced essential thrombocythemia was investigated at the molecular level. Our results demonstrate that mutations in exon-9 could lead to significant conformational variations of calreticulin structure and thereby reducing its interaction with calcium ions due to decreased electrostatic contributions. The consequence of mutations on calreticulins structural integrity was revealed by identifying the key residues and their roles in calcium binding. Furthermore, mutations implemented by CRISPR-Cas9 in exon-9 showed diminished calcium signaling in HEK-293T cells, which agree well with our in-silico findings. The current study might help in understanding of the interactions between calreticulin exon-9 INDEL and calcium ions mediated by the structural variations of calreticulin. The results provide useful information for designing novel therapeutic approaches targeting essential thrombocythemia.
- organism: human
- assay: proteomics
- research focus: cell signaling & trafficking
- approach: mechanistic / dynamical model
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Molecular and Functional Analysis of Calcium Binding by a Cancer-linked Calreticulin Mutant
Ishmael Nii Ayibontey Tagoe, Amanpreet Kaur, … Malini Raghavan·eLifePeer-reviewed·Oct 29, 2026
- Mpl is activated by dimers of MPN-linked calreticulin mutants stabilized by disulfide bonds and ionic interactions
A. Venkatesan, J. Geng, … M. Raghavan·bioRxiv·Sep 13, 2020
- A comprehensive analysis of calreticulin mutants reveals distinct biophysicochemical proprieties with a potential for refined targeted therapies
Orhan Nedim Kurt, Mustafa Baran Ozturk, … Ilyas Chachoua·bioRxiv·Jun 24, 2026
- CALR frameshift mutations in MPN patient-derived iPS cells accelerate maturation of megakaryocytes
K. Olschok, L. Han, … S. Koschmieder·Stem Cell ReportsPeer-reviewed·Nov 1, 2021
- Lysosomal Degradation Pathways Target Mutant Calreticulin and the Thrombopoietin Receptor in Myeloproliferative Neoplasms
A. Kaur, A. Venkatesan, … M. Raghavan·bioRxiv·Jul 12, 2023
- Effects of Calreticulin Mutations on HLA Class I Expression in Myeloproliferative Neoplasms
Amanpreet Kaur, Harini Desikan, … Malini Raghavan·bioRxiv·Jun 24, 2025